glp-1 monthly Printable Weight Loss Tracker Bundle: Daily, Weekly, (PDF Download) Save month after month on

Upcoming Removal of Selected GLP-1 Drugs from Medi-Cal Rx Effective January 1, 2026, Californias Medi-Cal Rx program will remove certain medications from its contract drug list

Retatrutide is Eli Lillys once weekly injectable that targets three pathways at the same time, GLP-1, GIP, and glucagon

GLP-1 medications are widely used for weight loss in patients with and without type 2 diabetes

In a pediatric population with limited treatment options beyond metformin and insulin, this represents a real therapeutic advancement for an underserved group

Results Mean weight dropped from 133 to 87 kg by year 2, with %EWL peaking at 68% and declining to 63% by year 5